FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19467611000001105: Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Aug 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
65807401000001119 Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
65807501000001115 Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) Is a Normal immunoglobulin human 4g/20ml solution for infusion vials true Inferred relationship Existential restriction modifier
Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) Has active ingredient Human immunoglobulin true Inferred relationship Existential restriction modifier
Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) Has specific active ingredient Normal immunoglobulin human false Inferred relationship Existential restriction modifier
Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) Is a Hizentra true Inferred relationship Existential restriction modifier
Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) Has specific active ingredient Normal human immunoglobulin true Inferred relationship Existential restriction modifier
Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) Has manufactured dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) 1 vial Has AMP True Hizentra 4g/20ml solution for infusion vials (CSL Behring UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start